8 unknown, 6 active not recruiting, 5 recruiting, 1 not yet recruiting. 9 Phase 2, 6 Not applicable, 3 Phase 1, 1 Phase 3.
Follow Core needle biopsy: new trials by email Literature Review of Core needle biopsy trials Research Report on Core needle biopsy
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Polatuzumab Vedotin, Mosunetuzumab, and Acalabrutinib for the Treatment of Mantle Cell Lymphoma, PAcMan Trial Polatuzumab Vedotin, Acalabrutinib, Mosunetuzumab - Mantle Cell Lymphoma | Phase 2 | Not yet recruiting | University of Washington | 27 | 2027-03-01 | 2026-11-02 |
| Response to Neoadjuvant Treatment in Locally Advanced Thyroid Cancer Multitarget Tyrosine Kinase Inhibitors, BRAF inhibitor dabrafenib and MEK inhibitor trametinib, RET Inhibitor - Thyroid Cancer, Thyroid Neoplasms | Recruiting | Fujian Medical University | 120 | 2025-12-23 | 2026-02-19 | |
| Study of Acquired Resistance to Alkylator Chemotherapy in Endocrine Neoplasms Core needle biopsy, Phlebotomy - Neuroendocrine (NE) Tumors, Endocrine Cancer | Recruiting | Uppsala University | 94 | 2025-03-01 | 2025-08-14 | |
| Cryobiopsy for Suspected Malignant Peripheral Lymphadenopathy Cryobiopsy, Core Needle Biopsy - Cryobiopsy of Peripheral Lymph Nodes | Not applicable | Unknown | San Antonio Uniformed Services Health Education Consortium | 490 | 2023-12-01 | 2023-11-07 |
| Zimberelimab and Quemliclustat in Combination With Chemotherapy for the Treatment of Patients With Borderline Resectable and Locally Advanced Pancreatic Adenocarcinoma Biospecimen Collection, Computed Tomography, Core Biopsy - Borderline Resectable Pancreatic Adenocarcinoma, Locally Advanced Pancreatic Ductal Adenocarcinoma | Phase 1 / Phase 2 | Recruiting | Jonsson Comprehensive Cancer Center | 141 | 2023-03-07 | 2026-11-09 |
| Testing A New Anti-cancer Drug Combination, Entinostat and ZEN003694, for Advanced and Refractory Solid Tumors BET Bromodomain Inhibitor ZEN-3694, Computed Tomography, Core Biopsy - Advanced Malignant Solid Neoplasm, Locally Advanced Pancreatic Carcinoma | Phase 1 / Phase 2 | Recruiting | National Cancer Institute (NCI) | 49 | 2022-11-16 | 2026-07-15 |
| Image-based AI Predictive Biomarkers for Precision Neoadjuvant Triple-negative Breast Cancer Treatment Core needle biopsy - Triple Negative Breast Cancer, Triple Negative Breast Neoplasms | Terminated | Ourotech, Inc. | 34 | 2022-06-06 | 2025-07-30 | |
| Camrelizumab and Apatinib for Neoadjuvant Therapy in Thyroid Cancer Camrelizumab and Apatinib, surgery, core needle biopsy - Thyroid Cancer | Phase 2 | Unknown | Fudan University | 31 | 2020-12-01 | 2020-11-03 |
| NeoVax With Nivolumab in Patients With Ovarian Cancer Nivolumab, NeoVax, Core Needle Biopsy - Ovarian Cancer | Phase 1 | Active not recruiting | Dana-Farber Cancer Institute | 22 | 2020-11-20 | 2026-10-08 |
| Comparison Study of Different Tumor Biopsy Method for Sentinel Lymph Node Biopsy in Breast Cancer Vacuum-Assisted Biopsy, Core Needle Biopsy, Intraoperative Excisional Biopsy - Breast Cancer, Sentinel Lymph Node | Not applicable | Unknown | Shandong Cancer Hospital and Institute | 600 | 2020-11-01 | 2020-10-27 |
| Topical Afimoxifene in Treating Patients With Breast Cancer Who Have Undergone Radiation Therapy on One Breast Afimoxifene, Core Biopsy, Questionnaire Administration - Cancer Survivor, Ductal Breast Carcinoma In Situ | Phase 2 | Active not recruiting | Northwestern University | 156 | 2020-02-17 | 2025-10-09 |
| Cryoablation for the Treatment of Metastatic Cancer Core Biopsy, Cryosurgery, Immunotherapeutic Agent - Metastatic Malignant Neoplasm | Not applicable | Active not recruiting | M.D. Anderson Cancer Center | 15 | 2019-12-23 | 2026-08-06 |
| RANKL Inhibition and Mammographic Breast Density Denosumab, Placebo, Calcium - Dense Breasts | Phase 2 | Active not recruiting | Washington University School of Medicine | 210 | 2019-08-27 | 2026-10-09 |
| A Phase II Clinical Trial Evaluating the Combination of Olaparib and Temozolomide for the Treatment of Advanced Uterine Leiomyosarcoma Computed Tomography, Core Biopsy, Magnetic Resonance Imaging - Stage III Uterine Corpus Leiomyosarcoma AJCC v8, Stage IV Uterine Corpus Leiomyosarcoma AJCC v8 | Phase 2 | Active not recruiting | National Cancer Institute (NCI) | 23 | 2019-08-19 | 2026-07-31 |
| Anlotinib Neoadjuvant Treatment in Locally Advanced Thyroid Cancer Anlotinib, surgery, core needle biopsy - Thyroid Cancer | Phase 2 | Unknown | Fudan University | 13 | 2019-06-01 | 2021-04-01 |
| Biomarker Study of Pancreatic Neuroendocrine Tumours 18F-FDG-PET, 68Ga-DOTATOC-PET, Computed tomography - Pancreatic Neuroendocrine Tumor | Unknown | Uppsala University | 40 | 2019-01-30 | 2022-05-18 | |
| RNA Disruption Assay (RDA)-Breast Cancer Response Evaluation for Individualized Therapy Core needle biopsy - Breast Neoplasm Female | Not applicable | Active not recruiting | Rna Diagnostics Inc. | 801 | 2018-04-26 | 2026-05-28 |
| Ascorbic Acid and Chemotherapy for the Treatment of Relapsed or Refractory Lymphoma, CCUS, and Chronic Myelomonocytic Leukemia Ascorbic Acid, Carboplatin, Cisplatin - Clonal Cytopenia of Undetermined Significance, High Grade B-Cell Lymphoma With MYC and BCL2 or BCL6 Rearrangements | Phase 2 | Recruiting | Mayo Clinic | 80 | 2018-03-23 | 2026-09-28 |
| Minimally Invasive Biopsy Predicting Breast pCR After NAC for Breast Cancer core needle biopsy - Breast Cancer | Not applicable | Unknown | Shandong Cancer Hospital and Institute | 50 | 2017-06-01 | 2018-12-31 |
| Biomarker Study in Pancreatic Neuroendocrine Tumours Core Needle Biopsy, Computed Tomography, 18F-FDG-PET - Neuroendocrine Tumors | Unknown | Uppsala University | 30 | 2017-05-01 | 2017-08-25 |
Showing 20 of 22. Sign in to see all of them.
Breast Neoplasms (5) · Thyroid Neoplasms (3) · Lymphoma (2) · Adenoma, Islet Cell (1) · Carcinoma, Intraductal, Noninfiltrating (1) · Endocrine Gland Neoplasms (1) · Hodgkin Disease (1) · Leukemia, Myelomonocytic, Chronic (1) · Lymphoma, Large B-Cell, Diffuse (1) · Lymphoma, Mantle-Cell (1) · Neoplasm Metastasis (1) · Neoplasms (1) · Neuroendocrine Tumors (1) · Ovarian Neoplasms (1) · Pancreatic Neoplasms (1)
Shandong Cancer Hospital and Institute (3) · Uppsala University (3) · Fudan University (2) · National Cancer Institute (NCI) (2) · Dana-Farber Cancer Institute (1) · Fujian Medical University (1) · Jonsson Comprehensive Cancer Center (1) · M.D. Anderson Cancer Center (1) · Mayo Clinic (1) · Northwestern University (1) · Ourotech, Inc. (1) · Philips Healthcare (1) · Rna Diagnostics Inc. (1) · San Antonio Uniformed Services Health Education Consortium (1) · University of Washington (1)
United States (12) · China (6) · Sweden (3) · Canada (1) · France (1) · Germany (1) · Italy (1) · Poland (1) · Spain (1) · United Kingdom (1)
Adetunji T Toriola, M.D., Ph.D. (1) · Alda L Tam (1) · Barbro Eriksson, MD PhD (1) · Daniele Generali, MD (1) · Eva Ciruelos, MD (1) · Foluso Ademuyiwa, MD (1) · Joakim Crona, MD PhD (1) · Joke Tio, MD (1) · Maureen Trudeau, MD (1) · Mia C Weiss (1) · Panagiotis Konstantinopoulos, MD (1) · Patricia M LoRusso (1) · Seema A Khan, M.D. (1) · Stephen D. Smith, MD (1) · Tao Yang, MD (1)
PMID 32693797, PMID 32996592, PMID 33927108, PMID 34610756, PMID 37467452, PMID 38113421, PMID 39352751, PMID 39863139, PMID 42875558
P30CA060553 (1), P50CA097274 (1), P50CA240243 (1), R37CA235602 (1), UM1CA186686 (1), UM1CA186689 (1)